We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

32 hedge funds and large institutions have $14.1M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

23% more capital invested

Capital invested by funds: $11.5M → $14.1M (+$2.65M)

14% more funds holding

Funds holding: 28 → 32 (+4)

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
2
Closed
3
Calls
$178K
Puts
–
Net Calls
+$178K
Net Calls Change
+$116K

Top Buyers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
+$1.66M
2
Walleye Trading
Walleye Trading
New York
+$217K
3
Renaissance Technologies
Renaissance Technologies
New York
+$119K
4
CC
Clearline Capital
New York
+$71.3K
5
JP Morgan Chase
JP Morgan Chase
New York
+$59.9K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$1.31M
2
EAM
Eventide Asset Management
Massachusetts
-$345K
3
PAM
Panagora Asset Management
Massachusetts
-$35.8K
4
Morgan Stanley
Morgan Stanley
New York
-$422
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$5.97M – – –
BI
2
BVF Inc
California
$1.83M – – –
SCM
3
Sio Capital Management
New York
$1.7M +$1.66M +3,936 New
Renaissance Technologies
4
Renaissance Technologies
New York
$1.32M +$119K +282 +10%
Vanguard Group
5
Vanguard Group
Pennsylvania
$933K +$7.17K +17 +0.8%
BlackRock
6
BlackRock
New York
$544K +$3.37K +8 +0.6%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$244K – – –
PAM
8
Panagora Asset Management
Massachusetts
$223K -$35.8K -85 -14%
Walleye Trading
9
Walleye Trading
New York
$222K +$217K +515 New
JP Morgan Chase
10
JP Morgan Chase
New York
$190K +$59.9K +142 +47%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$153K – – –
Walleye Capital
12
Walleye Capital
New York
$140K +$137K +324 New
BCM
13
Bridgeway Capital Management
Texas
$120K – – –
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$78K +$15.6K +37 +26%
CC
15
Clearline Capital
New York
$73K +$71.3K +169 New
Two Sigma Investments
16
Two Sigma Investments
New York
$57K – – –
Citadel Advisors
17
Citadel Advisors
Florida
$44K +$43.4K +103 New
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$42K – – –
ARTA
19
A.R.T. Advisors
New York
$42K +$15.6K +37 +60%
VF
20
Virtu Financial
New York
$41K +$21.9K +52 +118%
Northern Trust
21
Northern Trust
Illinois
$39K – – –
Bank of America
22
Bank of America
North Carolina
$27K +$10.1K +24 +62%
SPIA
23
Steward Partners Investment Advisory
New York
$24K – – –
Macquarie Group
24
Macquarie Group
Australia
$20K +$19.4K +46 New
RC
25
RBF Capital
California
$18K – – –
1
2

FRTX Hedge Fund Activity: Q3 2018 in Review

32 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q3 2018, worth a combined $14.1M — up 23% from $11.5M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new FRTX positions and 3 closed out — a net gain of 4 holders — while 9 added to existing stakes and 2 trimmed.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $1.66M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.31M sold.

  • 32 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q3 2018, up from 28 in Q2 2018.
  • Funds reported $14.1M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q3 2018, up 23% quarter-over-quarter.
  • 7 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q3 2018 and 3 closed out, a net change of +4 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q3 2018 was Sio Capital Management, an estimated $1.66M added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q3 2018 was Perceptive Advisors, an estimated $1.31M sold.

Based on aggregated 13F filings for Q3 2018.